Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Analysis of Bad Debts

Microsoft Excel

Allowance for doubtful accounts receivable (bad debts) is a contra account which reduce the balance of the company gross accounts receivable. The relationship between the allowance and the balance in receivables should be relatively constant unless there is a change in the economy overall or a change in customer base.


Allowance for Doubtful Accounts Receivable

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Allowance for expected credit loss 23 22 21 18 21
Trade receivables, gross 8,905 8,173 8,000 7,237 6,497
Financial Ratio
Allowance as a percentage of trade receivables, gross1 0.26% 0.27% 0.26% 0.25% 0.32%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Allowance as a percentage of trade receivables, gross = 100 × Allowance for expected credit loss ÷ Trade receivables, gross
= 100 × 23 ÷ 8,905 = 0.26%

Financial ratio Description The company
Allowance as a percentage of trade receivables, gross Allowance for doubtful accounts divided by the gross accounts receivable. Bristol-Myers Squibb Co. allowance as a percentage of trade receivables, gross increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.